First FDA-approved study of focused ultrasound to open blood-brain barrier

August 9, 2018, University of Maryland

In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of MRI-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).

The blood-brain barrier is a specialized network of vascular and brain cells that acts as the brain's security system, helping to safeguard the brain and regulate the flow of substances into and out of it. While this network protects the brain, it also limits doctors' ability to deliver effective doses of disease-fighting drugs to the brain, particularly in the case of , which are notoriously treatment-resistant. This safety and feasibility study is a first step in attempting to overcome a major hurdle in treating these often-deadly cancers.

"The ability to temporarily disrupt the blood-brain barrier without causing tissue damage has the potential to dramatically alter the landscape of drug delivery to the brain for many diseases," says the principal investigator, Graeme F. Woodworth, MD, professor of neurosurgery at UMSOM and director of the Brain Tumor Treatment and Research Center at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) at UMMC.

"If successful, this approach would allow us to use chemotherapy and other therapies in the brain in ways that are currently not possible," says Dr. Woodworth, noting that 98 percent of currently approved drugs don't enter the brain because of the blood-brain barrier. "If we can selectively open the blood-brain barrier, then in the future we could give a much lower dose of powerful drugs, which would likely reduce toxic side effects and make treatments safer and more effective for patients."

The process involves injecting microscopic inert gas-filled bubbles into a patient's bloodstream and then oscillating the microbubbles (causing them to move back and forth) with highly targeted sound waves, stretching the blood vessel walls to create temporary openings.

The U.S. Food and Drug Administration (FDA) approved the clinical trial in October 2017 after a lengthy review process. Although there are similar research studies in Canada and other countries, this was the first time the FDA approved a clinical study using this promising technology and approach.

Within a few months, University of Maryland researchers expect to open another FDA-approved clinical trial in which newly diagnosed glioblastoma patients will undergo blood-brain barrier opening prior to treatment with standard chemotherapy, temozolomide. This new ultrasound-augmented approach would target the areas where tumor recurrence would be most likely to occur.

Nearly 80,000 people are diagnosed with a each year; 26,000 of these tumors are malignant. Glioblastoma is the most common type of brain cancer and the most deadly. Patients live an average of 15 months after diagnosis; the average five-year survival is only 5.5 percent.

Dr. Graeme Woodworth, University of Maryland neurosurgeon, explains the potential benefit of using MRI-guided focused ultrasound to open the blood-brain barrier. He is leading the first FDA-approved clinical study using this approach in patients with brain cancer. Credit: University of Maryland Medical Center
"Glioblastoma is the most aggressive and lethal type of brain tumor, but treatment has been severely limited by our inability to get chemotherapy and other therapeutics through the blood-brain barrier," says Kevin J. Cullen, MD, the Marlene and Stewart Greenebaum Distinguished Professor in Oncology at UMSOM and director of the UMGCCC. "Dr. Woodworth's study is an important first step in finding an effective way to administer drug therapies that would improve patients' quality of life and increase their survival."

In the initial study, researchers plan to enroll up to 15 patients with suspected glioblastoma, an aggressive , who will undergo surgery at UMMC to remove their tumor.

The morning of the scheduled surgery, patients will undergo a standard magnetic resonance imaging (MRI) scan as part of the preoperative planning process. Guided by this MRI, doctors will target a precise region within the tumor with ultrasound, while the injected microbubbles are circulating within the bloodstream. The microbubbles will oscillate within the ultrasound field, causing temporary openings in the walls of the , and allowing the MRI contrast agent, gadolinium, to pass into the brain tissue. The MRI scan will then be completed, documenting the extent to which the blood-brain barrier was disrupted.

The data from the MRI will be used in a system called intraoperative stereotactic neuro-navigation—an advanced 3-D-guidance system that accurately localizes the tumor within the . After the surgery, researchers will also rigorously examine the tissue that was removed to study the potential therapeutic and other effects from the focused ultrasound procedure.

In this initial trial, the increased amount of contrast enhancement within the tumor provided by the focused ultrasound procedure may help the 3-D navigation during the surgery, according to Dr. Woodworth. "The standard of care is not changing in regard to the surgical procedure. We are functionally increasing the amount of navigation data available to the surgeon," he says.

Dr. Woodworth notes that the disruption in the is not permanent, lasting about four to six hours.

The clinical trial is sponsored by InSightec, which has developed the MRI-guided focused ultrasound technology that will be used in the study. Neurosurgeons at UMMC are also using this technology to treat patients with neurological conditions, such as essential tremor and Parkinson's disease, the latter as part of a clinical research study.

"MRI-guided focused ultrasound holds great promise in treating a variety of medical conditions, from cancer to Parkinson's disease," says UMSOM Dean E. Albert Reece, MD, Ph.D., MBA, executive vice president for medical affairs at UM Baltimore and the John Z. and Akiko K. Bowers Distinguished Professor. "Our physician-scientists are leading major research studies and are at the forefront of efforts to determine how this new technology can be used to provide better treatments for patients."

Explore further: Ultrasound jiggles open brain barrier, a step to better care

Related Stories

Ultrasound jiggles open brain barrier, a step to better care

July 25, 2018
A handful of Alzheimer's patients signed up for a bold experiment: They let scientists beam sound waves into the brain to temporarily jiggle an opening in its protective shield.

Blood-brain barrier opened noninvasively with focused ultrasound for the first time

November 10, 2015
The blood-brain barrier has been non-invasively opened in a patient for the first time. A team at Sunnybrook Health Sciences Centre in Toronto used focused ultrasound to enable temporary and targeted opening of the blood-brain ...

Noninvasive brain tumor biopsy on the horizon

April 26, 2018
Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple ...

Implantable ultrasound device augments chemo in glioblastoma

June 16, 2016
(HealthDay)—An implantable ultrasound device (SonoCloud) appears to enhance chemotherapy treatment in glioblastoma, according to research published online June 15 in Science Translational Medicine.

A delicate crossing: Controller developed to open the blood-brain barrier with precision

November 15, 2017
The blood-brain barrier - the semi-permeable membrane that surrounds the brain - offers important protection for a delicate organ, but in some cases, clinicians need to get past the barrier to deliver vital drugs to treat ...

Experimental drug combined with radiation kills brain tumors in pre-clinical studies

June 27, 2018
A new study led by scientists at VCU Massey Cancer Center has shown that an experimental drug known as AZ32 selectively sensitizes brain tumors to radiation and significantly extends the survival of mouse models with human ...

Recommended for you

Neurons with good housekeeping are protected from Alzheimer's

December 17, 2018
Some neurons in the brain protect themselves from Alzheimer's with a cellular cleaning system that sweeps away toxic proteins associated with the disease, according to a new study from Columbia University and the University ...

Measuring speed of mental replay of movies gives new insight into accessing memories

December 17, 2018
Researchers have discovered that 'fully detailed' memories are stored in the /, but people access this information at different speeds and levels of detail, with people accessing memories 'forward' that is recalling older ...

Tuning arousal to boost information transmission in the brain

December 17, 2018
Columbia neural engineers discover a mechanism by which the locus coeruleus modulates information processing in the thalamus; their findings of how sensory information is encoded in the healthy brain may lead to new treatments ...

Gently stroking babies before medical procedures may reduce pain processing

December 17, 2018
Researchers found that gently stroking a baby seems to reduce activity in the infant brain associated with painful experiences. Their results, appearing December 17 in the journal Current Biology, suggest that lightly brushing ...

Tiny implantable device short-circuits hunger pangs, aids weight loss

December 17, 2018
More than 700 million adults and children worldwide are obese, according to a 2017 study that called the growing number and weight-related health problems a "rising pandemic."

Discovery of a novel way synapses can regulate neuronal circuits

December 17, 2018
The fundamental process of information transfer from neuron to neuron occurs through a relay of electrical and chemical signaling at the synapse, the junction between neurons. Electrical signals, called action potentials, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.